Senesco Technologies Inc. (NYSE:ELOX)’s stock price fell 5.1% during trading on Friday . The stock traded as low as $4.36 and last traded at $4.48, 17,459 shares changed hands during mid-day trading. A decline of 94% from the average session volume of 314,318 shares. The stock had previously closed at $4.72.
The firm’s 50 day simple moving average is $6.52 and its 200 day simple moving average is $6.22.
Senesco Technologies (NYSE:ELOX) last announced its quarterly earnings results on Tuesday, November 5th. The company reported ($0.32) EPS for the quarter, beating the consensus estimate of ($0.39) by $0.07.
Eloxx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Its lead program is ELX-02, which is in Phase I clinical trial, which focuses on the treatment of cystic fibrosis and cystinosis patients with diagnosed nonsense mutations.
Featured Article: What is a Tariff?
Receive News & Ratings for Senesco Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senesco Technologies and related companies with MarketBeat.com's FREE daily email newsletter.